Since 1 January 2020, the federal government has been supporting companies that carry out innovative and risky research and development (R&D) in Germany through the Act on Tax Incentives for Research and Development (Forschungszulagengesetz, FZulG). This funding covers all areas of technology and is available to companies of all sizes.
Since the law came into force, the research allowance has already been optimised several times and currently supports a large number of project-related costs, also in combination. These include:
- R&E personnel costs (including social security expenses)
- Costs for contract research with contractors within the European Economic Area
- Project-related depreciation for projects starting after 27 March 2024
- Own work by self-employed persons or working owners of partnerships
These eligible costs in their entirety form the assessment basis for the research allowance.
Continuous improvement of the research allowance
When the law was introduced, the maximum assessment basis per year for a group of companies was two million euros, subsidised with an allowance of 25 percent. This upper limit was raised to four million euros in the same year.
With the Growth Opportunities Act 2024, the limit for expenses after 27 March 2024 rose to ten million euros per year. The law also introduced the inclusion of depreciation and an increased subsidy rate of 35 per cent for small and medium-sized enterprises.
Investment programme strengthens research funding
The immediate tax investment programme, which was approved by the Federal Council on 11 July 2025, further improves the conditions of the research allowance:
- Increase in the maximum assessment basis for a group of companies to twelve million euros per year for expenses incurred after 31 December 2025.
- Flat-rate consideration of additional overheads and other operating costs through a 20 percent surcharge on further eligible expenses - valid for projects starting after 31 December 2025.
- Faster depreciation options through the so-called "investment booster", which can lead to higher depreciation in the project period and could therefore result in an increased research allowance.
Your path to research funding – roadmap
Your path to the research allowance
More KPMG insights for you
Your contacts
- Item 1
- Item 2
- Item 3